Life sciences briefing: Thursday, Dec. 27, 2007

Successful CMOs achieve growth by leveraging technology. Join us for GrowthBeat Summit on June 1-2 in Boston, where we'll discuss how to merge creativity with technology to drive growth. Space is limited. Request your personal invitation here!

TODAY’S HEADLINES:

perfint-logo-150px.gifIndia’s Perfint, medical-device co., raises $3.5M – Perfint, a Chennai, India-based producer of medical equipment, raised $3.5 million in a new funding round.

IDG Ventures India and Erasmus Venture Fund provided the cash. IDG supplied the bulk of the investment — $3 million — with Erasmus providing the rest.

Perfint’s first product, the PIGA-CT, is a tool positioner for minimally invasive procedures. The PIGA-CT is designed to work with a variety of compact CT scanners for image-guided positioning.

source-mdx-logo-150px.gifSource MDx strikes Pfizer partnership to ID cancer, inflammation “fingerprints” – Source MDx, a Boulder, Colo., developer of molecular diagnostics, struck a multi-year partnership with Pfizer. The two companies will identify and validate “biomarkers” — essentially, any sort of biochemical signal, such as levels of a particular protein or RNA snippet — that can be used to track the effect of a drug or predict the course of disease.

The collaboration will focus on Pfizer’s cancer and inflammation drug-development programs. Financial details weren’t disclosed, although Pfizer will make an equity investment in Source MDx and pay both a technology licensing fee and R&D costs. Source MDx will retain commercial rights to diagnostic biomarkers discovered and validated by the partnership.


VentureBeat’s VB Insight team is studying marketing analytics... Chime in here, and we’ll share the results.